High Impact Medicines for All
We strive to discover breakthrough medicines which would have high impact on health care. We are not limited to one region or one therapeutical area. Instead, we leverage resources and expertise world-wide and combine it with our own unique perspectives to solve challenging medical problems. In all projects we take on, we seek to have high competitive advantages to differentiate from competition.
Learn more about the latest news on innovative drug development!
Sutent inventor and serial entrepreneur Chris Liang believes Hangzhou Highlightll’s TYK2/JAK1 inhibitor could deliver dual selectivity without the toxicity of a more advanced Pfizer compound against the same targets to treat a broad range of autoimmune diseases. Both compounds would need to find a foothold in a crowded marketplace.